Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid LeukemiaJohn C. Byrd, Peter Hillmen, Paul M. Barr et al.|New England Journal of Medicine|2014Cited by 1.6k
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upBarbara Eichhorst, Ulrich Mey, Tadeusz Robak et al.|Annals of Oncology|2020Cited by 568
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLLIan W. Flinn, Stephan Stilgenbauer, Peter Hillmen et al.|Blood|2018Cited by 341
Evolutionary history of transformation from chronic lymphocytic leukemia to Richter syndromeErin M. Parry, Jennifer R. Brown, Ignaty Leshchiner et al.|Nature Medicine|2023Cited by 83
Evolutionary History of Transformation from Chronic Lymphocytic Leukemia to Richter SyndromeErin M. Parry, Catherine J. Wu, Romain Guièze et al.|Blood|2022Cited by 10